BlackRock, Inc.
- SEC CIK
- 0002012383
VRTX holding history
VERTEX PHARMACEUTICALS INC / MA
Every 13F filing in which BlackRock, Inc. reported holding VRTX, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 24,109,373 | $11.98B | 0.18% | +139,856+0.6% | Added |
| Q1 2026 | 23,969,517 | $10.7B | 0.19% | +217,528+0.9% | Added |
| Q4 2025 | 23,751,989 | $10.77B | 0.18% | +1,498,942+6.7% | Added |
| Q3 2025 | 22,253,047 | $8.72B | 0.15% | +381,102+1.7% | Added |
| Q2 2025 | 21,871,945 | $9.74B | 0.19% | +89,012+0.4% | Added |
| Q1 2025 | 21,782,933 | $10.56B | 0.22% | −42,537−0.2% | Reduced |
| Q4 2024 | 21,825,470 | $8.79B | 0.18% | +37,924+0.2% | Added |
| Q3 2024 | 21,787,546 | $10.13B | 0.21% | +21,787,546 | New |